← Browse by Condition
Medical Condition

classical hodgkin lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT06563245 Phase 2, Phase 3
Recruiting

Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

Enrollment
96 pts
Location
China
Sponsor
Children's Cancer Group, China
View Trial →